BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 25044768)

  • 1. The changes of leukocyte telomere length and telomerase activity after sitagliptin intervention in newly diagnosed type 2 diabetes.
    Ma D; Yu Y; Yu X; Zhang M; Yang Y
    Diabetes Metab Res Rev; 2015 Mar; 31(3):256-61. PubMed ID: 25044768
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association study of leukocyte telomere length and genetic polymorphism within hTERT promoter with type 2 diabetes in Bangladeshi population.
    Goswami A; Huda N; Yasmin T; Hosen MI; Hasan AKMM; Nabi AHMN
    Mol Biol Rep; 2021 Jan; 48(1):285-295. PubMed ID: 33389530
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Associations of TERC Single Nucleotide Polymorphisms with Human Leukocyte Telomere Length and the Risk of Type 2 Diabetes Mellitus.
    Al Khaldi R; Mojiminiyi O; AlMulla F; Abdella N
    PLoS One; 2015; 10(12):e0145721. PubMed ID: 26720590
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between oxidative stress and telomere length in Type 1 and Type 2 diabetic patients.
    Ma D; Zhu W; Hu S; Yu X; Yang Y
    J Endocrinol Invest; 2013 Dec; 36(11):1032-7. PubMed ID: 23873360
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Leukocyte telomere length is associated with complications of type 2 diabetes mellitus.
    Testa R; Olivieri F; Sirolla C; Spazzafumo L; Rippo MR; Marra M; Bonfigli AR; Ceriello A; Antonicelli R; Franceschi C; Castellucci C; Testa I; Procopio AD
    Diabet Med; 2011 Nov; 28(11):1388-94. PubMed ID: 21692845
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of sitagliptin or metformin added to pioglitazone monotherapy in poorly controlled type 2 diabetes mellitus patients.
    Derosa G; Maffioli P; Salvadeo SA; Ferrari I; Ragonesi PD; Querci F; Franzetti IG; Gadaleta G; Ciccarelli L; Piccinni MN; D'Angelo A; Cicero AF
    Metabolism; 2010 Jun; 59(6):887-95. PubMed ID: 20015525
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Telomerase activity and telomere length in lymphocytes from patients with cutaneous T-cell lymphoma.
    Wu K; Lund M; Bang K; Thestrup-Pedersen K
    Cancer; 1999 Sep; 86(6):1056-63. PubMed ID: 10491534
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of leukocyte telomere length with type 2 diabetes in mainland Chinese populations.
    Shen Q; Zhao X; Yu L; Zhang Z; Zhou D; Kan M; Zhang D; Cao L; Xing Q; Yang Y; Xu H; He L; Liu Y
    J Clin Endocrinol Metab; 2012 Apr; 97(4):1371-4. PubMed ID: 22319045
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sitagliptin use and risk of acute pancreatitis in type 2 diabetes mellitus: A population-based case-control study in Taiwan.
    Liao KF; Lin CL; Lai SW; Chen WC
    Eur J Intern Med; 2016 Jan; 27():76-9. PubMed ID: 26433909
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of the dipeptidyl peptidase-4 inhibitor sitagliptin added to ongoing pioglitazone therapy in patients with type 2 diabetes: a 24-week, multicenter, randomized, double-blind, placebo-controlled, parallel-group study.
    Rosenstock J; Brazg R; Andryuk PJ; Lu K; Stein P;
    Clin Ther; 2006 Oct; 28(10):1556-68. PubMed ID: 17157112
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Shortening of the leucocytes' telomeres length in T2DM independent of age and telomerase activity.
    AlDehaini DMB; Al-Bustan SA; Ali ME; Malalla ZHA; Sater M; Giha HA
    Acta Diabetol; 2020 Nov; 57(11):1287-1295. PubMed ID: 32500358
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of comprehensive lifestyle changes on telomerase activity and telomere length in men with biopsy-proven low-risk prostate cancer: 5-year follow-up of a descriptive pilot study.
    Ornish D; Lin J; Chan JM; Epel E; Kemp C; Weidner G; Marlin R; Frenda SJ; Magbanua MJM; Daubenmier J; Estay I; Hills NK; Chainani-Wu N; Carroll PR; Blackburn EH
    Lancet Oncol; 2013 Oct; 14(11):1112-1120. PubMed ID: 24051140
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanisms for the antihyperglycemic effect of sitagliptin in patients with type 2 diabetes.
    Muscelli E; Casolaro A; Gastaldelli A; Mari A; Seghieri G; Astiarraga B; Chen Y; Alba M; Holst J; Ferrannini E
    J Clin Endocrinol Metab; 2012 Aug; 97(8):2818-26. PubMed ID: 22685234
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Leukocyte telomere length correlates with glucose control in adults with recently diagnosed type 2 diabetes.
    Rosa ECCC; Dos Santos RRC; Fernandes LFA; Neves FAR; Coelho MS; Amato AA
    Diabetes Res Clin Pract; 2018 Jan; 135():30-36. PubMed ID: 29107760
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Helicobacter pylori eradication increases telomere length in gastric mucosa.
    Aslan R; Bektas A; Bedir A; Alacam H; Aslan MS; Nar R; Yildirim B; Goren I; Ecemis O; Ustaoglu M; Goren F; Okuyucu A
    Hepatogastroenterology; 2013 May; 60(123):601-4. PubMed ID: 23108080
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insulin treatment affects leukocyte telomere length in patients with type 2 diabetes: 6-year longitudinal study.
    Zeng JB; Liu HB; Ping F; Li W; Li YX
    J Diabetes Complications; 2019 May; 33(5):363-367. PubMed ID: 30857946
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impaired telomere length and telomerase activity in peripheral blood leukocytes and granulosa cells in patients with biochemical primary ovarian insufficiency.
    Xu X; Chen X; Zhang X; Liu Y; Wang Z; Wang P; Du Y; Qin Y; Chen ZJ
    Hum Reprod; 2017 Jan; 32(1):201-207. PubMed ID: 27836977
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of adding sitagliptin, a dipeptidyl peptidase-4 inhibitor, to metformin on 24-h glycaemic control and beta-cell function in patients with type 2 diabetes.
    Brazg R; Xu L; Dalla Man C; Cobelli C; Thomas K; Stein PP
    Diabetes Obes Metab; 2007 Mar; 9(2):186-93. PubMed ID: 17300594
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of Interleukin-23 and
    Rezaeepoor M; Hoseini-Aghdam M; Sheikh V; Eftekharian MM; Behzad M
    J Interferon Cytokine Res; 2020 Nov; 40(11):515-523. PubMed ID: 33136467
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of the dipeptidyl peptidase-4 inhibitor, sitagliptin, in patients with type 2 diabetes mellitus inadequately controlled on glimepiride alone or on glimepiride and metformin.
    Hermansen K; Kipnes M; Luo E; Fanurik D; Khatami H; Stein P;
    Diabetes Obes Metab; 2007 Sep; 9(5):733-45. PubMed ID: 17593236
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.